GLP-1 drugs Archives - Word on Benefits

Multiemployer Plan and Public Employer Coverage of GLP-1 Drugs

Cara McMullin

26 Jun 202426 Jun 2024

New Survey Data Reveals Total Reported Annual Claim Representation for GLP-1 Drugs for Weight Loss Is Almost Ten Percent A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer and plan sponsor coverage surrounding glucagon-like peptide-1 […]

Disease Management Employee Benefits Health Care Insurance Prescription Drugs U.S.

Employer Coverage of GLP-1 Drugs on the Rise

Cara McMullin

13 Jun 202413 Jun 2024

New Survey Data Reveals Total Reported Annual Claim Representation for GLP-1 Drugs for Weight Loss Has Increased to Almost Nine Percent A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage surrounding glucagon-like peptide-1 (GLP-1) […]

Employee Benefits Health Care Prescription Drugs Wellness

Employer’s Role in the Obesity Epidemic

Amanda Wilke, CEBS

14 May 202421 May 2024

The latest theme to hit employer-provided benefits is GLP-1 drug coverage and the costs to treat obesity while reducing other health risks. To properly respond to the obesity epidemic, employers must understand obesity, weight bias and stigma, and the effect obesity has […]

Canada Employee Benefits Health Care Human Resources (HR) Prescription Drugs

GLP-1 Drug Coverage in Canada

Cara McMullin

12 Feb 202421 Feb 2024

A new survey report from the International Foundation of Employee Benefit Plans reveals results from a group of Canadian employers regarding considerations and coverage for glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes and are increasingly being used […]